January 19, 2021
Optimal SARS-CoV-2 Vaccine Allocation Using Real-Time Seroprevalence Estimates in Rhode Island and Massachusetts
Category: Article Summary
Topic: Modeling and Prediction
Keywords (Tags): vaccination
Vaccine allocation models parametrized to the seroprevalence estimates of Rhode Island and Massachusetts show that allocating >75% of the vaccine supply to individuals ≥70 years old optimally reduces total cumulative deaths through mid-2021. Although not explicitly modelled, allocating a majority of the supply to other high-risk groups will yield the same effect. Vaccinating seronegative individuals only avoids redundancy and could result in 1-2% reductions in cumulative hospitalizations.
Tran et al. (Jan 15, 2021). Optimal SARS-CoV-2 Vaccine Allocation Using Real-Time Seroprevalence Estimates in Rhode Island and Massachusetts. Pre-print downloaded Jan 19 from https://doi.org/10.1101/2021.01.12.21249694